Evidence map›Paper›PMID 25381598›Full record

ArticleWorld journal of surgical oncology2014

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.

Heejeong Lee, Kyu Rae Kim, Nam Hoon Cho, Sung Ran Hong, Hoiseon Jeong, Sun Young Kwon, Kwang Hwa Park, Hee Jung An, Tae Heon Kim, Insun Kim and 12 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in World journal of surgical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. MiR-34b-5p Suppresses Melanoma Differentiation-Associated Gene 5 (Frontiers in cellular and infection microbiology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 1 country.

Heejeong Lee
Kyu Rae Kim
Nam Hoon Cho
Sung Ran Hong
Hoiseon Jeong
Sun Young Kwon
Kwang Hwa Park
Hee Jung An
Tae Heon Kim
Insun Kim
Hye Kyoung Yoon
Kwang Sun Suh
Ki Ouk Min
Hyun Joo Choi
Ji Young Park
Chong Woo Yoo
Youn Soo Lee
Hee Jin Lee
Weon Sun Lee
Chul Soo ParkDepartment of Internal Medicine, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 137-701, Korea. charlie@catholic.ac.kr.
Yonghee Lee
Gynecological Pathology Study Group of the Korean Society of Pathologists
Catholic University of Korea · KRCHA University · KRThe Catholic University of Korea Bucheon St. Mary's Hospital · KRYonsei University · KRAjou University · KRCatholic Kwandong University · KRCheil General Hospital and Women's Healthcare Center · KRChungnam National University · KRInje University · KRKeimyung University · KRKorea University · KRKyungpook National University · KRNational Cancer Center · KRUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroRNA (miRNA) expression is known to be deregulated in cervical carcinomas. However, no data is available about the miRNA expression pattern for the minimal deviation adenocarcinoma (MDA) of uterine cervix. We sought to detect deregulated miRNAs in MDA in an attempt to find the most dependable miRNA or their combinations to understand their tumorigenesis pathway and to identify diagnostic or prognostic biomarkers. We also investigated the association between those miRNAs and their target genes, especially Notch1 and Notch2.

methodsWe evaluated miRNA expression profiles via miRNA microarray and validated them using.real-time PCR assays with 24 formalin-fixed, paraffin-embedded tissue blocks of MDA and 11 normal proliferative endocervical tissues as control. Expression for Notch1 and 2 was assessed by immunohistochemistry.

resultsMiRNA-135a-3p, 192-5p, 194-5p, and 494 were up-regulated, whereas miR-34b-5p, 204-5p, 299-5p, 424-5p, and 136-3p were down-regulated in MDA compared with normal proliferative endocervical tissues (all P<0.05). Considering the second-order Akaike Information Criterion consisting of likelihood ratio and number of parameters, miR-34b-5p showed the best discrimination power among the nine candidate miRNAs. A combined panel of miR-34b-5p and 194-5p was the best fit model to discriminate between MDA and control, revealing 100% sensitivity and specificity. Notch1 and Notch2, respective target genes of miR-34b-5p and miR-204-5p, were more frequently expressed in MDA than in control (63% vs. 18%; 52% vs. 18%, respectively, P<0.05). MiR-34b-5p expression level was higher in Notch1-negative samples compared with Notch1-positive ones (P<0.05). Down-regulated miR-494 was associated with poor patient survival (P=0.036).

conclusionsMDA showed distinctive expression profiles of miRNAs, Notch1, and Notch2 from normal proliferative endocervical tissues. In particular, miR-34b-5p and 194-5p might be used as diagnostic biomarkers and miR-494 as a prognostic predictor for MDA. The miR-34b-5p/Notch1 pathway as well as Notch2 might be important oncogenic contributors to MDA.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAdenocarcinomaAdultBiomarkers, TumorCase-Control StudiesCervix UteriFemaleFollow-Up StudiesHumansMicroRNAsMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisReal-Time Polymerase Chain ReactionBiomarkers, TumorMicroRNAsNOTCH1 protein, humanNOTCH2 protein, humanReceptor, Notch1Receptor, Notch2

Identifiers

PMID25381598
PMCPMC4239392
OpenAlexW2162796928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.